產(chǎn)品詳情
簡(jiǎn)單介紹：
Anti-C12ORF49抗體產(chǎn)品質(zhì)量穩(wěn)定，實(shí)驗(yàn)效果明顯，貨期快，價(jià)格優(yōu)惠，歡迎垂詢訂購(gòu)！我公司長(zhǎng)期供應(yīng)**組化抗體、WB抗體、**組化試劑盒和抗體試驗(yàn)所需全部相關(guān)試劑、熒光標(biāo)記抗體、單克隆抗體、多克隆抗體、各種標(biāo)記的二抗IgG/IgM/IgD/IgA等科研實(shí)驗(yàn)抗體。Anti-C12ORF49抗體用于**組化實(shí)驗(yàn),WB實(shí)驗(yàn),相應(yīng)的標(biāo)記抗體有HRP標(biāo)記抗體,FITC標(biāo)記,BIO等。
詳情介紹：
Rabbit Anti-C12ORF49
Cat. Number:
Anti-C12ORF49抗體KL-9949R
Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Encoding over 1,100 genes within 132 million bases, chromosome 12 makes up about 4.5% of the human genome. A Anti-C12ORF49抗體number of skeletal deformities are linked to chromosome 12 including hypochondrogenesis, achondrogenesis and Kniest dysplasia. Noonan syndrome, which includes heart and facial developmental defects among the primary symptoms, is caused by a mutant form of PTPN11 gene product, SH-PTP2. Chromosome 12 is also home to a homeobox gene cluster which encodes crucial transcription factors for morphogenesis, and the natural killer complex gene cluster encoding C-type lectin proteins which mediate the NK cell response to MHC I interaction. Trisomy 12p leads to facial development defects, seizure disorders and a host of other symptoms varying in severity depending on the extent of mosaicism and is most severe in cases of complete trisomy. The C12orf49 gene product has been provisionally designated C12orf49 pending further characterization.
Also known as:
Chromosome 12 Anti-C12ORF49抗體open reading frame 49; Hypothetical protein LOC79794; UPF0454 protein C12orf49 homolog; CL049_HUMAN.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Chicken, Dog, Pig, Cow, Horse, Zebrafish, .
●
Immunogen: KLH conjugated synthetic peptide derived from human C12ORF49.
●
Predicted Molecular Weight: 24kDa.
Storage:
Shipped at 4℃, Anti-C12ORF49抗體Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 IF=1:50-200
Not yet tested in other applications.
Optimal working Anti-C12ORF49抗體dilutions must be determined by the end user.
Not yet tested in other applications.
Optimal working Anti-C12ORF49抗體dilutions must be determined by the end user.
kl065Mu02 白介素1受體Ⅱ(IL1R2)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type II (IL1R2)
kl066Mu02 白介素1受體Ⅰ(IL1R1)多克隆抗體 Polyclonal Antibody to Interleukin 1 Receptor Type I (IL1R1)
kl068Mu02 神經(jīng)膠質(zhì)纖維酸性蛋白(GFAP)多克隆抗體 Polyclonal Antibody to Glial Fibrillary Acidic Protein (GFAP)
kl071Mu02 白介素1α(IL1α)多克隆抗體 Polyclonal Antibody to Interleukin 1 Alpha (IL1a)
kl072Bo01 防御素β2(DEFβ2)多克隆抗體 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl072Mu02 防御素β2(DEFβ2)多克隆抗體 Polyclonal Antibody to Defensin Beta 2 (DEFb2)
kl073Mu02 白介素2(IL2)多克隆抗體 Polyclonal Antibody to Interleukin 2 (IL2)
kl074Mu02 **球蛋白G1(IgG1)多克隆抗體 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl074Ra01 **球蛋白G1(IgG1)多克隆抗體 Polyclonal Antibody to Immunoglobulin G1 (IgG1)
kl076Mu02 白介素3(IL3)多克隆抗體 Polyclonal Antibody to Interleukin 3 (IL3)
kl077Gu01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Mu02 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Ov01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl077Si01 白介素4(IL4)多克隆抗體 Polyclonal Antibody to Interleukin 4 (IL4)
kl078Mu02 白介素5(IL5)多克隆抗體 Polyclonal Antibody to Interleukin 5 (IL5)
kl079Mu02 白介素6(IL6)多克隆抗體 Polyclonal Antibody to Interleukin 6 (IL6)
kl081Mu02 白介素9(IL9)多克隆抗體 Polyclonal Antibody to Interleukin 9 (IL9)
kl083Mu02 瘦素受體(LEPR)多克隆抗體 Polyclonal Antibody to Leptin Receptor (LEPR)
kl084Mu02 瘦素(LEP)多克隆抗體 Polyclonal Antibody to Leptin (LEP)
kl086Mu02 L選擇素(SELL)多克隆抗體 Polyclonal Antibody to Selectin, Leukocyte (SELL)
